Alsdorf, Germany

Markus Sack

This inventor holds 5 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2004-2021.

USPTO Granted Patents = 5 

% Patents Active = 20.0

 

Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Aachen, DE (2004)
  • Alsdorf, DE (2018 - 2021)

Company Filing History:


Years Active: 2004-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Markus Sack

Introduction

Markus Sack is a notable inventor based in Alsdorf, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of novel fermentation systems and malaria vaccines. With a total of 5 patents to his name, his work has the potential to impact both medical and industrial applications.

Latest Patents

One of Markus Sack's latest patents focuses on fermentation systems. This innovation pertains to novel cell cultivation and cell and/or cell-derived product production processes that offer advantages over existing fermentation strategies. The methods described in this patent aim to provide an efficient supply of highly viable and metabolically active eukaryotic cells for transient production platforms. This alternative production process presents benefits over currently applied methods such as batch, fed-batch, or perfusion strategies. Additionally, it facilitates the generation of metabolically active biomass for subsequent use in transient expression systems or infection by a virus or pseudovirus, as well as in cell-free systems.

Another significant patent is related to a three-component multistage malaria vaccine. This technology involves novel malaria vaccines composed of different recombinant proteins, particularly recombinant fusion proteins that include various antigens from the pre-erythrocytic, blood, and sexual stages of the malaria parasite. The proteins can be utilized in a mixture vaccine formulation to elicit protective immune responses in humans. The patent also covers nucleic acid molecules encoding these recombinant proteins, vectors, and host cells containing the nucleic acids, along with methods for preparation and production of such proteins. Furthermore, it discusses antibodies induced by the use of these malaria vaccines and their potential for passive immunotherapy.

Career Highlights

Markus Sack is currently affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading organization in applied research in Europe. His work at this institution has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of Markus Sack's notable coworkers include Holger Spiegel and Rainer Fischer. Their collaborative efforts have further advanced the research and development of innovative solutions in biotechnology.

Conclusion

Markus Sack's contributions to the fields of fermentation systems and malaria vaccine development highlight his role as a significant inventor in biotechnology. His innovative patents reflect a commitment to advancing scientific knowledge and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…